<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03549364</url>
  </required_header>
  <id_info>
    <org_study_id>2017/429-31</org_study_id>
    <nct_id>NCT03549364</nct_id>
  </id_info>
  <brief_title>Pilot Study of Myocardial Effects Following an Endurance Race</brief_title>
  <official_title>A Pilot Study of the Myocardial Effects of an Endurance Race as Evaluated by Computer Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ten healthy subjects perform a baseline computer tomography (CT) of the heart and routine
      laboratory blood tests for myocardial injury and inflammation.

      The same data are collected &lt;24 hours after an endurance race corresponding to a maraton run
      (i.e. about 40 km of running and/or about 2.5 hours hard training or more). A third
      collection of lab tests and CT is done a couple of weeks after the race. Magnetic resonance
      imaging is also performed in parallell to the CT on occasions 2 and 3 in most subjects,
      serving as a reference for determination of myocardial blood flow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ten healthy subjects perform a baseline computer tomography (CT) of the heart and routine
      laboratory blood tests (troponin T, hs-CRP, CK-mb etc) for myocardial injury and
      inflammation.

      The same data are collected &lt;24 hours after an endurance race corresponding to a maraton run
      (i.e. about 40 km of running and/or about 2.5 hours hard training or more). A third
      collection of lab tests and CT is done a couple of weeks after the race. Magnetic resonance
      imaging (MRI) is also performed in parallell to the CT on occasions 2 and 3 in most subjects,
      serving as a reference for determination of myocardial blood flow. The CT of the heart
      includes contrast injection and blood flow will be determined by a recently developed based
      on very powerful computers using &quot;machine learning&quot;.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 24, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in myocardial blood flow by the race?</measure>
    <time_frame>All investigations are performed &lt; 2 months</time_frame>
    <description>Detection of potential differences in blood flow between occasion 1 and 2 and 3</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Myocardial Blood Flow</condition>
  <arm_group>
    <arm_group_label>Endurance race</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>baseline investigations with CT and lab tests
the same CT and lab tests &lt; 24h after an endurance race
CT and lab tests again about 1-2weeks after the race</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Endurance Race</intervention_name>
    <description>1 CT and lab tests, 2 CT and lab tests within 24h of a race, 3 follow up investigations 1-2 weeks after the race with CT and lab tests</description>
    <arm_group_label>Endurance race</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy subjects, experienced in long distance running

        Exclusion Criteria:

        Significant renal, kidney, heart, liver or musculoskeletal disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fredrik H Nystr√∂m, MD PhD Professor</last_name>
    <phone>0736569303</phone>
    <phone_ext>+46</phone_ext>
    <email>fredrik.h.nystrom@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Linkoping</name>
      <address>
        <city>Linkoping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fredrik H Nystrom, MD, prof.</last_name>
    </contact>
    <contact_backup>
      <phone>+46736569303</phone>
      <email>fredrik.h.nystrom@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Fredrik H Nystrom, MD PhD prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 11, 2018</study_first_submitted>
  <study_first_submitted_qc>May 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2018</study_first_posted>
  <last_update_submitted>April 23, 2019</last_update_submitted>
  <last_update_submitted_qc>April 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Fredrik H Nystrom</investigator_full_name>
    <investigator_title>MD PhD professor head of internal medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

